SecBot SecBot
6-K ·Filed Oct 27, 2026

PHAR

Pharming Group N.V.
BULLISH
Impact 6/10
Processed10h 37m ago SEC0001828316-26-000049
Notable filing: 6-K

Price Chart

Loading chart...

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001828316-26-000049
Document: 0001828316-26-000049-index-headers.html0001828316-26-000049
Document: 0001828316-26-000049-index.html0001828316-26-000049
Document: 0001828316-26-000049.txt0001828316-26-000049
16 reports for PHAR
Performance horizon
50% Hit rate @ T+1 6 of 12 directional calls Went positive at some point 8 of 12 best @ T+20▲ +10.43%Jun 4, 2026
Filters
Rows
Reports for PHAR — sortable, filterable
TypeNow
Oct 27, 2026
today
6-K
BULLISH ★ 6/10
$11.55awaiting T+1—$11.87 (+2.77%)
Oct 27, 2026
today
Press Release
BULLISH ★ 6/10
$11.55awaiting T+1—$11.87 (+2.77%)
Oct 22, 2026
5d ago
6-K
BULLISH ★ 6/10
$10.67 $11.20▲ +4.97%▲ +5.49%$11.87 (+11.25%)
Oct 14, 2026
13d ago
6-K
BULLISH ★ 6/10
$9.64 $9.63▼ −0.10%▼ −0.39%$11.87 (+23.13%)
Sep 29, 2026
28d ago
6-K
BEARISH ★ 5/10
$10.01 $9.99▲ +0.20%▼ −0.01%$11.87 (−18.58%)
Sep 29, 2026
28d ago
Press Release
BEARISH ★ 6/10
$10.01 $9.99▲ +0.20%▼ −0.01%$11.87 (−18.58%)
Sep 25, 2026
4w ago
6-K
BULLISH ★ 6/10
$10.46 $10.52▲ +0.57%▲ +1.32%$11.87 (+13.48%)
Sep 25, 2026
4w ago
Press Release
BULLISH ★ 5/10
$10.46 $10.52▲ +0.57%▲ +1.32%$11.87 (+13.48%)
Sep 22, 2026
5w ago
6-K
BULLISH ★ 6/10
$11.26 $10.77▼ −4.35%▼ −3.63%$11.87 (+5.42%)
Sep 11, 2026
6w ago
6-K
BULLISH ★ 7/10
$11.21 $10.82▼ −3.48%▼ −3.03%$11.87 (+5.89%)
Showing 10 of 16

US Market Status

Market Closed — Opens Wed (15h 40m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 27, 2026

Fresh PHAR Intelligence

Analysis is for subscribers only.

Subscribe for Full Access